Neelima Alluri, MD | |
211 Park St, Attleboro, MA 02703-3143 | |
(508) 236-7430 | |
Not Available |
Full Name | Neelima Alluri |
---|---|
Gender | Female |
Speciality | Anesthesiology |
Experience | 31 Years |
Location | 211 Park St, Attleboro, Massachusetts |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1033110952 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207L00000X | Anesthesiology | 221212 (Massachusetts) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Milford Regional Medical Center | Milford, MA | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Milford Anesthesia Consultants Pc | 0446671333 | 37 |
News Archive
A group of Senate negotiators, known as the Gang of Six, held a teleconference today to discuss their efforts to craft a bipartisan reform bill in the Finance Committee, USA Today reports. The group, which includes three Republicans and three Democrats, went into the call on the heels of a rough patch, with Sen. Charles Grassley, R-Iowa, asking supporter for help defeating "Obama-care" and Democrats attacking Sen. Mike Enzi, R-Wyo., for making critical remarks.
CytRx Corporation, a biopharmaceutical company specializing in oncology, today announced that it has initiated an open-label Phase 1b safety and dose escalation clinical trial with INNO-206 at the Sarcoma Oncology Center in Santa Monica, California. The clinical trial will include up to 24 patients with advanced solid tumors who have failed standard therapies.
Miglustat is a drug currently under phase 2 clinical trials on patients suffering from cystic fibrosis (1). Its potential for treating the disease was discovered in 2006 thanks to the work of Frédéric Becq's team at the Institute of Cell Physiology and Biology (CNRS/Université de Poitiers), funded by the associations Vaincre la Mucoviscidose, MucoVie66, La Pierre Le Bigaut and ABCF2.
Novel biomedical advances that show promise in the lab often fall short in clinical trials. For researchers studying peripheral artery disease, this is made more difficult by a lack of standardized metrics for what recovery looks like.
In an effort to protect children from harmful tobacco smoke exposure, health and medical professionals are pushing for a ban on smoking in public housing in a report appearing in this week's New England Journal of Medicine.
› Verified 5 days ago
Entity Name | Milford Anesthesia Associates Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1871679118 PECOS PAC ID: 4981669959 Enrollment ID: O20041201000713 |
News Archive
A group of Senate negotiators, known as the Gang of Six, held a teleconference today to discuss their efforts to craft a bipartisan reform bill in the Finance Committee, USA Today reports. The group, which includes three Republicans and three Democrats, went into the call on the heels of a rough patch, with Sen. Charles Grassley, R-Iowa, asking supporter for help defeating "Obama-care" and Democrats attacking Sen. Mike Enzi, R-Wyo., for making critical remarks.
CytRx Corporation, a biopharmaceutical company specializing in oncology, today announced that it has initiated an open-label Phase 1b safety and dose escalation clinical trial with INNO-206 at the Sarcoma Oncology Center in Santa Monica, California. The clinical trial will include up to 24 patients with advanced solid tumors who have failed standard therapies.
Miglustat is a drug currently under phase 2 clinical trials on patients suffering from cystic fibrosis (1). Its potential for treating the disease was discovered in 2006 thanks to the work of Frédéric Becq's team at the Institute of Cell Physiology and Biology (CNRS/Université de Poitiers), funded by the associations Vaincre la Mucoviscidose, MucoVie66, La Pierre Le Bigaut and ABCF2.
Novel biomedical advances that show promise in the lab often fall short in clinical trials. For researchers studying peripheral artery disease, this is made more difficult by a lack of standardized metrics for what recovery looks like.
In an effort to protect children from harmful tobacco smoke exposure, health and medical professionals are pushing for a ban on smoking in public housing in a report appearing in this week's New England Journal of Medicine.
› Verified 5 days ago
Entity Name | Milford Anesthesia Consultants Pc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1437784261 PECOS PAC ID: 0446671333 Enrollment ID: O20200601002798 |
News Archive
A group of Senate negotiators, known as the Gang of Six, held a teleconference today to discuss their efforts to craft a bipartisan reform bill in the Finance Committee, USA Today reports. The group, which includes three Republicans and three Democrats, went into the call on the heels of a rough patch, with Sen. Charles Grassley, R-Iowa, asking supporter for help defeating "Obama-care" and Democrats attacking Sen. Mike Enzi, R-Wyo., for making critical remarks.
CytRx Corporation, a biopharmaceutical company specializing in oncology, today announced that it has initiated an open-label Phase 1b safety and dose escalation clinical trial with INNO-206 at the Sarcoma Oncology Center in Santa Monica, California. The clinical trial will include up to 24 patients with advanced solid tumors who have failed standard therapies.
Miglustat is a drug currently under phase 2 clinical trials on patients suffering from cystic fibrosis (1). Its potential for treating the disease was discovered in 2006 thanks to the work of Frédéric Becq's team at the Institute of Cell Physiology and Biology (CNRS/Université de Poitiers), funded by the associations Vaincre la Mucoviscidose, MucoVie66, La Pierre Le Bigaut and ABCF2.
Novel biomedical advances that show promise in the lab often fall short in clinical trials. For researchers studying peripheral artery disease, this is made more difficult by a lack of standardized metrics for what recovery looks like.
In an effort to protect children from harmful tobacco smoke exposure, health and medical professionals are pushing for a ban on smoking in public housing in a report appearing in this week's New England Journal of Medicine.
› Verified 5 days ago
Mailing Address | Practice Location Address |
---|---|
Neelima Alluri, MD Po Box 6208, Providence, RI 02940-6208 Ph: (201) 804-2800 | Neelima Alluri, MD 211 Park St, Attleboro, MA 02703-3143 Ph: (508) 236-7430 |
News Archive
A group of Senate negotiators, known as the Gang of Six, held a teleconference today to discuss their efforts to craft a bipartisan reform bill in the Finance Committee, USA Today reports. The group, which includes three Republicans and three Democrats, went into the call on the heels of a rough patch, with Sen. Charles Grassley, R-Iowa, asking supporter for help defeating "Obama-care" and Democrats attacking Sen. Mike Enzi, R-Wyo., for making critical remarks.
CytRx Corporation, a biopharmaceutical company specializing in oncology, today announced that it has initiated an open-label Phase 1b safety and dose escalation clinical trial with INNO-206 at the Sarcoma Oncology Center in Santa Monica, California. The clinical trial will include up to 24 patients with advanced solid tumors who have failed standard therapies.
Miglustat is a drug currently under phase 2 clinical trials on patients suffering from cystic fibrosis (1). Its potential for treating the disease was discovered in 2006 thanks to the work of Frédéric Becq's team at the Institute of Cell Physiology and Biology (CNRS/Université de Poitiers), funded by the associations Vaincre la Mucoviscidose, MucoVie66, La Pierre Le Bigaut and ABCF2.
Novel biomedical advances that show promise in the lab often fall short in clinical trials. For researchers studying peripheral artery disease, this is made more difficult by a lack of standardized metrics for what recovery looks like.
In an effort to protect children from harmful tobacco smoke exposure, health and medical professionals are pushing for a ban on smoking in public housing in a report appearing in this week's New England Journal of Medicine.
› Verified 5 days ago
Shari Lurie, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 211 Park St, Anesthesia Dept., Attleboro, MA 02703 Phone: 508-236-7430 | |
Uttara G Bhimani, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 211 Park St, Attleboro, MA 02703 Phone: 508-236-7430 | |
Mark Lebovits, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 211 Park St, Anesthesia Department, Attleboro, MA 02703 Phone: 508-236-7430 Fax: 508-236-7446 | |
Dr. Mohammed Bilal Chaudary, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 211 Park St, Attleboro, MA 02703 Phone: 508-222-5200 | |
Do Chan, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 211 Park St, Anesthesia Department, Attleboro, MA 02703 Phone: 508-236-7430 | |
Boris Shwartzman, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 211 Park St, Attleboro, MA 02703 Phone: 508-236-7430 |